Application of fluorescence in the identification of circulating tumor cells

Abstract

Abstract:There are many ways to identify circulating tumor cells in the current. Fluorescence has a wide range of applications in the identification of circulating tumor cells. The labeled cells can be observed and counted more intuitively by labeling the tumor cells with fluorescent group containing antibodies, probes and aptamers, and cytokine, CD45 and fluorescence in situ hybridization are widely used in the identification of various circulating tumor cell related tests. In recent years, people have explored the feasibility of using fluorescent probes to directly identify circulating tumor cells. With the development of biopsy probes and optical sectioning imaging technology of confocal microscopy, it is possible to directly identify circulating tumor cells with fluorescent probes in the future.

Key words:Neoplasm circulating cells,Fluorescence,In situ hybridization, fluorescence,Probe

Yu Huajie*, Han Lu, Ou Yang, Li Sheng, Gao Dehai. Application of fluorescence in the identification of circulating tumor cells[J]. Journal of International Oncology, 2018, 45(1): 35-.

References

［1］ Hong B, Zu Y. Detecting circulating tumor cells: current challenges and new trends［J］. Theranostics, 2013, 3(6): 377394. DOI: 10.7150/thno.5195. ［2］ Ashworth TR. A case of cancer in which cells similar to those in tumors were seen in the blood after death［J］. Aust Med, 1869, 14: 146149. ［3］ Yagi S, Koh Y, Akamatsu H, et al. Development of an automated sizebased filtration system for isolation of circulating tumor cells in lung cancer patients［J］. PLoS One, 2017, 12(6): e0179744. DOI: 10.1371/journal. pone.0179744. ［4］ Reyes EE, Gillard M, Duggan R, et al. Molecular analysis of CD133positive circulating tumor cells from patients with metastatic castrationresistant prostate cancer［J］. J Transl Sci, 2015, 1(1): pii: http://oatext.com/MolecularanalysisofCD133positivecirculatingtumorcellsfrompatientswithmetastaticcastrationresistantprostatecancer.php. ［5］黄文涛. 胆道肿瘤循环肿瘤细胞的检测及基因组扩增［D］ . 福州: 福建医科大学, 2015. ［6］ Wong VC, Ko JM, Lam C. Succinct workflows for circulating tumor cells after enrichment: from systematic counting to mutational profiling［J］. PLoS One, 2017, 12(5): e0177276. DOI: 10.1371/journal.pone.0177276. ［7］苏喜. 新型磁性碳量子点设计制备及其用于CTC检测研究［D］ . 重庆: 重庆大学, 2015. ［8］ Gonzales PR, Mikhail FM. Diagnostic and prognostic utility of fluorescence in situ hybridization (FISH) analysis in acute myeloid leukemia［J］. Curr Hematol Malig Rep, 2017, 12(6): 568573. DOI: 10.1007/s11899 01704266. ［9］ Swennenhuis JF, Tibbe AG, Levink R, et al. Characterization of circulating tumor cells by fluorescence in situ hybridization［J］. Cytometry A, 2009, 75(6): 520527. DOI: 10.1002/cyto.a.20718. ［10］张玉娟. 循环肿瘤细胞检测的方法学建立和改良及在实体瘤中的监测应用研究［D］ . 北京: 北京协和医学院, 2014. ［11］张浩强, 李明辉, 王臻, 等. 免疫荧光联合原位杂交技术检测骨肉瘤患者外周血中循环肿瘤细胞的表达及临床意义［J］. 中华肿瘤杂志, 2017, 39(7): 485489. DOI: 10.3760/cma.j.issn.02533766.2017.07.002. ［12］ Liu H, Sun B, Wang S, et al. Circulating tumor cells as a biomarker in pancreatic ductal adenocarcinoma［J］. Cell Physiol Biochem, 2017, 42(1): 373382. DOI: 10.1159/000477481. ［13］ Wu W, Zhang Z, Gao XH, et al. Clinical significance of detecting circulating tumor cells in colorectal cancer using subtraction enrichment and immunostainingfluorescence in situ hybridization (SEiFISH)［J］. Oncotarget, 2017, 8(13): 2163921649. DOI: 10.18632/oncotarget.15452. ［14］ Zhang HQ, Gao P, Xiao X, et al. A liquid biopsybased method for the detection and quantification of circulating tumor cells in surgical osteosarcoma patients［J］. Int J Oncol, 2017, 50(4): 10751086. DOI: 10.3892/ijo.2017.3905. ［15］ Xu Y, Qin T, Li J, et al. Detection of circulating tumor cells using negative enrichment immunofluorescence and an in situ hybridization system in pancreatic cancer［J］. Int J Mol Sci, 2017, 18(4): 10. DOI: 10.3390/ijms18040622. ［16］ Frithiof H, Aaltonen K, Rydén L, et al. A FISHbased method for assessment of HER2 amplification status in breast cancer circulating tumor cells following CellSearch isolation［J］. Onco Targets Ther, 2016, 9: 70957103. DOI:10.2147/OTT.S118502. ［17］ Leversha MA, Han J, Asgari Z, et al. Fluorescence in situ hybridization analysis of circulating tumor cells in metastatic prostate cancer［J］. Clin Cancer Res, 2009, 15(6): 20912097. DOI: 10.1158/10780432.CCR082036. ［18］刘勇. 双光子细胞膜和核糖核酸探针的合成及其在活细胞荧光成像中的应用［D］ . 济南: 山东大学, 2014. ［19］ Kojima T, Hashimoto Y, Watanabe Y, et al. A simple biological imaging system for detecting viable human circulating tumor cells［J］. J Clin Invest, 2009, 119(10): 31723181. DOI: 10.1172/JCI38609. ［20］ Satelli A, Mitra A, Cutrera JJ, et al. Universal marker and detection tool for human sarcoma circulating tumor cells［J］. Cancer Res, 2014, 74(6): 16451650. DOI: 10.1158/00085472.CAN131739. ［21］方帅. 上转换纳米探针在循环肿瘤细胞的富集和检测中的应用［D］ . 苏州: 苏州大学, 2014. ［22］贾真珍. 循环肿瘤细胞的捕获及胞内雌激素受体检测探针的设计与合成［D］ . 济南: 山东师范大学, 2015. ［23］ Hwang JY, Kim ST, Han HS, et al. Optical aptamer probes of fluorescent imaging to rapid monitoring of circulating tumor cell［J］. Sensors (Basel), 2016, 16(11): E1909. DOI: 10.3390/s16111909. ［24］张鹏. 血液中循环肿瘤细胞的捕集与SER成像检测其相关蛋白质组学研究新技术的开发［D］ . 上海: 复旦大学, 2014.

[1]	Chen Luojun, Li Na, Tian Jingyuan, Song Qibin, Yu Jinming.Progress of circulating tumor cells in clinical application[J]. Journal of International Oncology, 2018, 45(8): 552-555.
[2]	Li Zhijian, He De.Research progress on liquid biopsy in pancreatic cancer[J]. Journal of International Oncology, 2018, 45(3): 180-182.
[3]	ZOU Jiang, GUO Xiao-Lan.Advances of liquid biopsy in the diagnosis and treatment of tumor[J]. Journal of International Oncology, 2018, 45(2): 107-111.
[4]	Zhao Xiaolei, Li Sanhua, Liu Lingling, Liang Yongbo, Niu Yinyin, Zhai Jinyu, Xu Yuyin, Qiu Jinkui, Qi Hua.Detection of ALK gene rearrangement in nonsmall cell lung cancer[J]. Journal of International Oncology, 2016, 43(5): 340-342.
[5]	LIN Jian-Ying, YANG Xi-Hong, GUO Hai-Peng, XU Man-Bin, XU Shao-Wei, PENG Han-Wei.Application of near infrared fluorescence imaging with indocyanine green in sentinel node biopsy for cN0 oral carcinoma[J]. Journal of International Oncology, 2016, 43(2): 86-.
[6]	Xie Qinghua, Zhu Hua, Liu Fei, Han Xuedi, Xia Chuanqin, Yang Zhi.Advance of molecular imaging probes targeted for EphB4 receptor[J]. Journal of International Oncology, 2016, 43(11): 841-844.
[7]	Shi Yusheng, Peng Yonghua, Sheng Shuyue, Zhang Xingmei.Aptamers as molecular probes in tumor molecular imaging[J]. Journal of International Oncology, 2016, 43(11): 838-840.
[8]	Liu Fei, Zhu Hua, Lin Xinfeng, Luo Zheng, Li Nan, Yang Zhi.Glutamine and tumor metabolism and their applications in nuclear medicine[J]. Journal of International Oncology, 2015, 42(2): 122-125.
[9]	Ni-Ting, WANG Yu-Dong.Dissemination, detection and clinical use of circulating tumor cell[J]. Journal of International Oncology, 2015, 42(11): 841-844.
[10]	Gao Yang, Yuan Zhou.Research progress of nanotechnology in circulating tumor cell[J]. Journal of International Oncology, 2015, 42(1): 46-48.
[11]	WANG Huan-Sheng, LI Pang, LI Sheng.Establishment of circulating tumor cell linesWang[J]. Journal of International Oncology, 2014, 41(11): 805-807.
[12]	XIA Fan, ZHAO Teng, WANG Yan.Detection technique of circulating tumour cells in lung cancer[J]. Journal of International Oncology, 2012, 39(7): 523-525.
[13]	ZHANG Yu, NI Ze-称, HU Lan-Ting, ZHANG Ning, WANG Qing.Diagnostic application value of urothelial carcinoma of the urinary bladder by dual color fluorescence in-situ hybridization[J]. Journal of International Oncology, 2012, 39(3): 237-240.